UnitedHealth Group Q3 2026 earnings: profit beat extends recovery, guidance raised

October 13, 2026

UnitedHealth beat profit and revenue estimates in Q3 2026 and raised its full-year guidance, extending its recovery from a rough 2025.

Key takeaways

• Adjusted profit came in at $4.69 per share on $112.7 billion in revenue, beating Wall Street’s roughly $4.19 EPS and $112.5 billion revenue estimates — a sizable beat that extends a string of better-than-expected quarters this year.
• The medical care ratio — the share of premium dollars paid out for members’ medical claims — was 88.4%. That figure was helped by $610 million in favorable adjustments to prior periods’ claims reserves, meaning the company had previously set aside more than it ultimately needed to cover 2026 claims.
• Overhead costs fell relative to revenue: the operating cost ratio dropped to 12.8% from 13.5% a year earlier, which management attributed to benefit-design changes and efficiency improvements in care delivery.
• UnitedHealth raised its full-year 2026 adjusted earnings outlook to at least $20.50 per share, up from the $19.50-to-$20.00 range it had set in July, saying the increase reflects how the business performed through the first three quarters of the year.
• The quarter continues a rebound from a difficult 2025, when a cyberattack and a sharp rise in Medicare Advantage medical costs led the company to slash guidance and replace its CEO; the steep year-over-year drop in trailing EPS still reflects that earlier hit even as recent quarters have improved.
• Optum, the company’s health-services arm, covered more than 120 million people and generated $66.9 billion in revenue, while the UnitedHealthcare insurance segment covered 48.3 million people on $86.3 billion in revenue — together the two main engines behind the quarter’s results.
• Trailing-twelve-month profit margins remain thin — about 4.7% operating and 3.1% net — which is typical for a health insurer, since most of each premium dollar is passed through to pay medical bills rather than kept as profit; return on equity of roughly 14.4% shows the company is still generating a solid return on shareholders’ money despite those thin margins.
• Operating cash flow was $5.1 billion for the quarter, equal to about 1.2 times net income, a sign the company’s reported earnings are backed by real cash coming in rather than accounting adjustments.

How the stock took it

UnitedHealth Group Incorporated closed at $378.52 on Oct 12, 2026, the last session before the report, and at $395.62 on Oct 14, 2026, the first session after it — +4.5% across the report.

Closes from the market's daily record. Each figure spans the report date — from the last session that closed before it to the first that closed after — because a company may report before the open or after the close.

Fundamentals

Financial history →

Sources: company report